Harvard Bioscience Inc.

Harvard Bioscience Inc., operating through its Data Sciences International (DSI) division, is a global manufacturer of specialized biomedical research equipment and a self-certified small disadvantaged business headquartered in New Brighton, Minnesota. The company specializes in developing and manufacturing advanced physiological monitoring technologies, including wireless implantable telemetry transmitters, respiratory monitoring systems, data acquisition software, and related research instrumentation used in preclinical studies and medical research programs. Harvard Bioscience has established itself as a critical supplier of sophisticated scientific equipment to multiple federal agencies, providing essential tools that enable complex biomedical research across the defense, military healthcare, and civilian research sectors.

Harvard Bioscience has demonstrated extensive federal contracting activity across a diverse range of biomedical products and services. The company has delivered wireless implantable telemetry devices for various animal models including rats, mice, ferrets, and non-human primates; pre-implanted animals with telemetry transmitters; implantable devices such as HD-S02, HD-S10, HD-S11, HD-X02, L03, L11, and M11 implants; physiological monitoring systems including whole-body plethysmography (WBP) equipment for respiratory monitoring; data acquisition and analysis software platforms such as Ponemah, Finepointe, and Neuroscore systems; surgical services and implantation procedures; refurbishment and calibration services for telemetry equipment; bias flow components for inhalation systems; surgical supplies and instrumentation; and research consumables including reagents and tubes. The company has received prime contract awards from the Defense Health Agency, Department of Veterans Affairs, National Institutes of Health (including the National Heart Lung and Blood Institute, National Institute on Aging, National Institute on Drug Abuse, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Mental Health, and National Institute of Allergy and Infectious Diseases), Environmental Protection Agency, Food and Drug Administration, Department of Agriculture (USDA Agricultural Research Service), U.S. Army Medical Command, Centers for Disease Control and Prevention, and National Institute on Deafness and Other Communication Disorders. Contract awards have been made on both set-aside and non-set-aside bases, including total small business set-asides for awards from the USDA and Department of Veterans Affairs. Individual prime contract awards have ranged from approximately $8,300 to $332,036, with the majority structured as firm fixed-price purchase orders and blanket purchase agreement call orders. The company has also served as a subcontractor, with recent sub-award activity including purchases of telemetry components such as SOHO-X00 implants and SOHUB transceivers, as well as PhysioTel Digital M Series implants.

Harvard Bioscience holds a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $4.8 million, awarded on May 4, 2022, with a completion date of May 3, 2027. This indefinite delivery vehicle enables the Defense Health Agency, Army Medical Command, and other military health system partners to procure a comprehensive range of specialized biomedical research solutions through streamlined task order execution. The BPA encompasses telemetry acquisition equipment, pre-implanted animals with telemetry devices, hardware and software systems, software validation and data analysis services, refurbishment and calibration services, and surgical implantation services. Performance locations under the BPA include facilities in Mounds View, Minnesota; Aberdeen Proving Ground, Maryland; San Antonio, Texas; and Frederick, Maryland. Task orders issued under the BPA have generated over $1.5 million in cumulative procurement value, with individual call orders ranging from approximately $8,320 to $235,556. The BPA has been utilized for a diverse range of requirements including procurement of telemetry implants and devices, pre-implanted research animals, surgical supplies, equipment upgrades and system expansions, software systems and training, inhalation equipment and accessories, and specialized research support services. The Defense Health Agency and Army Medical Command have been the primary issuing agencies for task orders, demonstrating the strategic importance of Harvard Bioscience's specialized biomedical solutions to defense and military health sector research initiatives.